Press release |

Inaction by US pharmaceutical corporation Gilead to follow through on its so-called ‘access initiative’ leaves people unable to access a vital drug to treat a deadly infection.

Read more
Photograph by Albert Masias

What good is a breakthrough medicine if the people who need it can't afford it?